Updated: Jun 20, 2026

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging
Published on: December 15, 2014
Eri Kato1, Hideo Shigematsu1, Ai Amioka1
1Department of Surgical Oncology, Hiroshima University, Research Institute for Radiation Biology and Medicine, Hiroshima, Japan.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Interim magnetic resonance imaging (MRI) can accurately predict pathological complete response (pCR) in breast cancer patients receiving neoadjuvant chemotherapy (NAC), aiding early treatment decisions. While effective, its high false-positive rate requires caution for surgical de-escalation planning.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: